Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies.
Passardi A, Rapposelli IG, Scarpi E, Sullo FG, Bartolini G, Neri E, Ghigi G, Tontini L, Ercolani G, Monti M, Ruscelli S, Matteucci L, Valgiusti M, Frassineti GL, Romeo A. Passardi A, et al. Among authors: romeo a. Biomolecules. 2021 Aug 12;11(8):1200. doi: 10.3390/biom11081200. Biomolecules. 2021. PMID: 34439866 Free PMC article.
GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.
Milandri C, Polico R, Garcea D, Passardi A, Gardini A, Romeo A, Scarpi E, Rosetti P, Ridolfi L, La Barba G, Ricci M, Amadori D. Milandri C, et al. Among authors: romeo a. Hepatogastroenterology. 2011 Mar-Apr;58(106):599-603. Hepatogastroenterology. 2011. PMID: 21661438
SLUG silencing increases radiosensitivity of melanoma cells in vitro.
Arienti C, Tesei A, Carloni S, Ulivi P, Romeo A, Ghigi G, Menghi E, Sarnelli A, Parisi E, Silvestrini R, Zoli W. Arienti C, et al. Among authors: romeo a. Cell Oncol (Dordr). 2013 Apr;36(2):131-9. doi: 10.1007/s13402-012-0120-6. Epub 2012 Dec 19. Cell Oncol (Dordr). 2013. PMID: 23250725
Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up.
Parisi E, Genestreti G, Sarnelli A, Ghigi G, Arpa D, Burgio MA, Gavelli G, Rossi A, Scarpi E, Monti M, Tesei A, Polico R, Romeo A. Parisi E, et al. Among authors: romeo a. Radiat Oncol. 2019 Jun 24;14(1):112. doi: 10.1186/s13014-019-1317-x. Radiat Oncol. 2019. PMID: 31234868 Free PMC article. Clinical Trial.
Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663.
Passardi A, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Gardini A, Barba G, Pagan F, Casadei-Gardini A, Valgiusti M, Ferroni F, Frassineti GL, Romeo A. Passardi A, et al. Among authors: romeo a. Cancers (Basel). 2020 Jan 10;12(1):178. doi: 10.3390/cancers12010178. Cancers (Basel). 2020. PMID: 31936817 Free PMC article.
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial.
Passardi A, Rapposelli IG, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Avanzolini A, Cavaliere D, Rudnas B, Valgiusti M, Barone D, Ferroni F, Frassineti GL, Romeo A. Passardi A, et al. Among authors: romeo a. Ther Adv Med Oncol. 2020 Dec 8;12:1758835920977139. doi: 10.1177/1758835920977139. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33343722 Free PMC article.
1,069 results